Results 211 to 220 of about 23,251 (254)
Some of the next articles are maybe not open access.

Chronic lymphocytic leukaemia treatment

Blood Reviews, 1993
Advances in the understanding of the natural history and prognosis of chronic lymphocytic leukaemia (CLL) and the introduction of new drugs and strategies have renewed interest in the treatment of this disease. Clinical trials in patients stratified according to risk factors are useful to determine the efficacy of different treatments.
E, Montserrat, C, Rozman
openaire   +2 more sources

[Chronic lymphocytic leukaemia].

Ugeskrift for laeger, 2021
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the world with approximately 450 new cases yearly in Denmark. The disease is highly heterogeneous, and half of the patients will never require treatment. The standard treatment is chemoimmunotherapy, but highly effective targeted therapies are approved for patients with high-risk ...
Caspar, da Cunha-Bang   +2 more
openaire   +3 more sources

ZAP70 in chronic lymphocytic leukaemia

The International Journal of Biochemistry & Cell Biology, 2008
The protein tyrosine kinase zeta-chain associated protein kinase (ZAP70), normally expressed in T cells and a subset of B cells, is solely expressed in poor prognosis chronic lymphocytic leukaemia and implicated in enhanced B cell receptor signalling. As a result, the expression of this protein provides an ideal prognostic marker for the disease.
Amin S, Parker A, Mann J
openaire   +3 more sources

Splenectomy in Chronic Lymphocytic Leukaemia

Scandinavian Journal of Haematology, 1977
In a retrospective study it was endeavoured to evaluate the effects of splenectomy in chronic lymphocytic leukaemia (CLL) characterised by splenomegaly. The material comprises 42 patients subjected to the operation in the course of the past 20 years. In the majority the spleen weighed more than 1000 g.
B E, Christensen   +2 more
openaire   +2 more sources

Fludarabine in chronic lymphocytic leukaemia

Expert Opinion on Pharmacotherapy, 2006
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. Historically, CLL patients have received prednisone- or chlorambucil-containing regimens, resulting in modest responses and a slim chance of long-term survival.
Thomas, Elter   +2 more
openaire   +2 more sources

Management of Chronic Lymphocytic Leukaemia

Drugs & Aging, 2000
Chronic lymphocytic leukaemia (CLL) is the most common form of adult leukaemia in Western countries. The diagnosis requires mature-appearing lymphocytes in the peripheral blood to >5 x 10(9)/L. The immunophenotype typically includes B cell antigens CD19, CD20 and CD23, low expression of surface immunoglobulin and CD5+, with other T cell antigens absent.
N, Kalil, B D, Cheson
openaire   +2 more sources

Transient leukaemia cutis in chronic lymphocytic leukaemia

Clinical and Experimental Dermatology, 1997
Leukaemia cutis arises from cutaneous infiltration by neoplastic leukocytes or their precursors. Recent evidence suggests that this sign does not necessarily herald a poor prognosis. We describe a 72-year-old woman with B-cell chronic lymphatic leukaemia who developed a papular eruption of her breast at the site of a recent herpetic eruption. Histology
S H, Wakelin   +3 more
openaire   +3 more sources

Chronic Lymphocytic Leukaemia Developing in the Course of Chronic Myeloid Leukaemia

Leukemia & Lymphoma, 2002
Both chronic myeloid leukaemia (CML) and chronic lymphocytic leukaemia (CLL) are rare illnesses. Their co-existence has been previously reported, typically with CML following CLL. We report to our knowledge the first case of CLL developing some years after initial diagnosis of Philadelphia (Ph) chromosome positive CML.
R, Salim, L, Wang, K, Lin, R E, Clark
openaire   +2 more sources

Therapy of chronic lymphocytic leukaemia

Best Practice & Research Clinical Haematology, 2010
Rapid progress has been achieved recently in the management of chronic lymphocytic leukaemia (CLL). New insights into the molecular pathology of CLL have generated a plethora of biological markers that predict the prognosis and influence therapeutic decisions. Moreover, fludarabine, bendamustine and two monoclonal antibodies, alemtuzumab and rituximab,
openaire   +2 more sources

Chronic Lymphocytic Leukaemia: A Review of the Immuno-architecture

2005
Immunophenotyping of B cell chronic lymphocytic leukaemia (B-CLL) is usually performed by flow cytometry on cell suspensions obtained from peripheral blood, bone marrow or biopsied tissue. Immunohistochemical analysis on routine sections is less commonly performed; however, this approach allows the pathologist and the researcher to appreciate the ...
Rosati, S, Kluin, PM
openaire   +3 more sources

Home - About - Disclaimer - Privacy